Many Stryker corrosion lawyers have been working exhaustively since the recall of the Stryker Rejuvenate and ABGII hip implants in July of 2012. The Stryker Rejuvenate and ABGII were initially believed to be the “shining stars” of metal hip implants. This was due to an innovative design which allowed surgeons to more precisely fit the implant to body type and activity level. Despite the high hopes for the new hip implant design, Stryker corrosion attorneys note that adverse reports began coming in to the FDA not long after the approval of the devices in 2008 and 2009. Stryker corrosion lawyers have seen injuries to recipients of these recalled hip implants which range from minor to life-threatening.

Stryker metal poisoning symptoms can come without warning for those patients with a recalled Stryker Rejuvenate or ABGII metal hip implant. Patients who received a Rejuvenate or ABGII Stryker hip implant device following FDA approval for the devices in 2008 and 2009, believed these devices had been tested and were safe. In fact, literature for the devices assured patients that the innovative new design and the use of a ceramic ball made the Rejuvenate and ABGII much safer and long-lasting than the true all-metal hip devices. Unfortunately Stryker metal poisoning symptoms and metallosis symptoms were reported by patients soon after receiving their Stryker hip implant.

Many recipients of the Stryker Rejuvenate may well wonder what events led up to the recall of the hip implant device in July, 2012. Was the company aware of the Stryker Rejuvenate design problems prior to releasing the device? Was the propensity for Stryker Rejuvenate fretting known? Was sufficient safety testing done prior to release of the Rejuvenate or was consumer safety sacrificed in favor of a larger profit margin? While the entire truth may never be known, many attorneys and consumers feel that, at the very least, Stryker downplayed the risks of the implant device, even at the time of the recall.

Stryker’s Rejuvenate hip implant was recalled in July 2012 along with the ABGII. At the time of the Stryker Rejuvenate recall, the company stated a heightened risk of fretting and corrosion, leading to the release of metal ions into surrounding hip tissue and the bloodstream

Both the Stryker Rejuvenate and Stryker ABGII hip Stryker implant devices were recalled on July 6, 2012 after demonstrating an increased likelihood of fretting and corrosion which can lead tiny metal ions to flake away from the device, ending up in the surrounding hip tissue or the bloodstream.